CarboHyde at CPhI

Last week, the biggest pharma event of the year took place in Milan.

This is the world's largest pharmaceutical exhibition , which houses six individual pharma events covering all industry sectors – from ingredients and FDF to machinery, packaging, outsourcing and biopharmaceuticals.

If you have been to a CPHI event previously, you will know that the event is tailored to professionals in the pharmaceutical industry. Over 2,300 exhibitors showcased their products and services to ~60,000 attendees representing all areas of the pharmaceutical supply chain over a three-day period and under one roof.

CarboHyde was represented by two guys, Tamás Vargadi and Gergely Toth besides myself. In 3 days we concluded ~80 meetings and discussions with friends, partners, exhibitors and strangers we bumped into. With all its changes, I think this is still one of the best events to meet people, at literally everyone is there and you can find whatever you find.

We met Sugammadex manufacturers and users, cyclodextrin producers and formulators, CMOs, formulation experts, people both from R&D and procurement, not to mention BD and many more.

And who will be there to present cyclodextrins? You will be able to find many users, like Sugammadex API manufacturers, integrated pharma companies using CDs in their formulations as well as the biggest manufacturers like WACKER , Roquette , Cyclolab R&D Ltd. or Zibo Qianhui Biological Technology Co.,Ltd along with distributors as Ashland , Barentz .

If you have not tried CPHI yet, I highly recommend for 2025. Lifetime memory.

I would be delighted to hear suggestions for upcoming topics and engage in Q&A, so please feel free to add your impressions in the comments or via email at [email protected] . Thank you.

In the coming weeks, we will continue focusing on using cyclodextrins as active ingredients, disease by disease. Stay tuned!

If you like these brief communications,?Subscribe?to join 4200 cyclodextrin enthusiasts, and gain and share knowledge on current and novel applications, challenges, and possibilities.